DeepIntent launches Helix AI, an agentic platform to accelerate healthcare programmatic marketing, promising to shrink insight‑to‑action cycles from weeks to minutes and give marketers a conversational interface to the industry’s most comprehensive health data sets.
What Helix AI Is
Helix AI is the first purpose‑built, agentic artificial‑intelligence solution for the healthcare advertising ecosystem. Integrated into DeepIntent’s demand‑side platform, the tool lets users query patient and provider data, build audience segments, and launch campaigns across programmatic and social channels using natural‑language prompts. By marrying DeepIntent’s Helix™ data cloud—covering roughly 4 million HCPs and 250 million patient lives—with a conversational AI layer, the platform eliminates the manual, multi‑day workflows that have traditionally hampered healthcare media planning.
How the Technology Works
At its core, Helix AI leverages large-language-model (LLM) capabilities tuned on HIPAA‑compliant health data. Marketers type or speak queries such as “show me cardiology prescribers in the Midwest with > 10 % growth last quarter,” and the system instantly returns audience size, geographic distribution, and prescribing trends. The same interface can generate cross‑channel forecasts, recommend optimal media mixes, and surface performance KPIs—including Audience Quality (AQ) and verified HCP reach—without the need for separate analytics dashboards. Because the engine runs on DeepIntent’s Helix™ data lake, the insights remain grounded in verified, first‑party health information rather than generic third‑party signals.
Why the Announcement Matters
The healthcare ad tech market has been constrained by stringent privacy regulations and fragmented data sources. Gartner predicts that by 2027, 70 % of marketers will rely on AI for campaign planning, yet adoption has lagged due to compliance concerns. Helix AI sidesteps these hurdles by delivering AI‑driven insights within a fully HIPAA‑compliant environment, effectively democratizing advanced analytics for agencies that previously lacked in‑house data science teams. Forrester estimates that AI‑enabled planning tools can cut time‑to‑insight by up to 50 %, a claim that DeepIntent’s early beta testers have already corroborated.
Industry Impact and Competitive Context
Helix AI enters a crowded ad tech landscape where giants like Google, Amazon, and Microsoft are rolling out generic AI assistants for media buying. However, those solutions are built on broad consumer data and lack the granular, regulated health datasets that DeepIntent controls. Competing niche players—such as HealthX and Medialytics—offer data‑visualization platforms but still require separate steps for audience creation and activation. By unifying data ingestion, audience generation, and media execution under a single conversational UI, Helix AI creates a tighter feedback loop that could reshape how pharmaceutical brands allocate spend across CTV, OTT, and retail media networks.
What It Means for Enterprise Marketing Teams
For large health‑care advertisers, the platform translates into faster go‑to‑market strategies for new drug launches and more agile optimization of existing campaigns. Marketing ops can now ask the system to “identify prescribers who switched from competitor X to our product in the last six months” and instantly receive a ready‑to‑activate segment. The reduced latency also enables real‑time performance monitoring, allowing media buyers to pivot spend across programmatic, social, and CTV channels as market dynamics shift.
Potential Limitations
While Helix AI’s natural‑language interface lowers the barrier to insight, it still depends on the quality and recency of the underlying data. Agencies that rely heavily on third‑party data may find the platform’s first‑party focus restrictive. Moreover, the conversational model can occasionally misinterpret nuanced medical terminology, necessitating a verification step before large‑scale spend decisions.
Future Outlook
DeepIntent plans to extend Helix AI’s capabilities to include predictive modeling for patient adherence and integration with leading Customer Data Platforms such as Salesforce CDP and Adobe Experience Platform. If the roadmap materializes, the platform could become a central hub for end‑to‑end healthcare marketing—linking data ingestion, AI‑driven insight, and cross‑channel activation in a single SaaS offering.
Market Landscape
The healthcare advertising sector is projected to exceed $9 billion by 2028, driven by rising investment in digital channels and stricter data‑privacy mandates. Programmatic buying now accounts for roughly 35 % of total spend in the space, up from 20 % in 2022. At the same time, the rise of Connected TV and Over‑the‑Top (OTT) platforms has opened new inventory for pharma brands, but also increased the complexity of cross‑device attribution.
Compliance remains the dominant friction point. A 2023 IDC survey found that 62 % of health‑care marketers cite data‑privacy regulations as the biggest barrier to AI adoption. Solutions that embed compliance—like Helix AI’s HIPAA‑ready architecture—are therefore positioned to capture a larger share of the market.
The competitive arena features both cloud‑scale players (Google Ads AI, Amazon Advertising) and specialist firms (HealthX, Medialytics). The former leverage massive consumer graphs but lack health‑specific granularity; the latter provide deep data but often require separate activation tools. Helix AI’s hybrid approach—combining DeepIntent’s proprietary health data lake with an agentic AI layer—creates a differentiated value proposition that could force rivals to either acquire similar data assets or partner with compliant data providers.
Top Insights
- Speed to insight: Helix AI reduces audience‑building cycles from days to minutes, delivering up to a 50 % planning time cut in early beta tests.
- Compliance‑first AI: Built on a HIPAA‑compliant data cloud, the platform offers enterprise‑grade privacy that generic AI assistants cannot match.
- Unified workflow: Marketers can query, segment, and activate audiences across programmatic DSPs and social channels without leaving the conversational UI.
- Competitive edge: By integrating first‑party health data, Helix AI outpaces broader AI solutions from Google, Amazon, and Microsoft for pharma‑specific use cases.
- Enterprise impact: Faster insight loops enable real‑time media optimization, improving ROAS for drug launches and ongoing therapeutic campaigns.
Get in touch with our Adtech experts
